Marked inhibition of hepatic cytochrome P450 activity in cholesterol-induced atherosclerosis in rabbits

被引:20
作者
Irizar, A [1 ]
Ioannides, C [1 ]
机构
[1] Univ Surrey, Sch Biol Sci, Mol Toxicol Grp, Guildford GU2 5XH, Surrey, England
关键词
cytochrome P450; cholesterol; enzyme inhibition; glutathione S-transferase;
D O I
10.1016/S0300-483X(98)00009-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of the present study was to investigate the expression of major xenobiotic-metabolising cytochrome P450 proteins, and of other enzyme systems, in hepatic and extrahepatic tissues of rabbits rendered atherosclerotic by the dietary administration of 1% cholesterol diets for 8 weeks. Individual cytochrome P450 proteins were monitored using diagnostic substrates and immunologically in Western blot analysis. The activity of all hepatic isoforms studied was depressed in the atherosclerotic animals; when, however, apoprotein levels were determined immunologically, no major differences were evident between the control and the atherosclerotic rabbits. In vitro studies indicated that neither cholesterol nor palm oil inhibited cytochrome P450 activity. The effects of cholesterol treatment leading to atherosclerosis on kidney, heart and lung cytochrome P450 activities were isoform-and tissue-specific; no change was evident in the heart activities, but in the lung and kidney cytochrome P450 activities were clearly modulated by the treatment with cholesterol. Apoprotein levels did not always parallel the changes in activities. Western blot analysis of aortic cytochromes P450 revealed that administration of cholesterol-rich diets enhanced CYP2B and CYP3A apoprotein levels. Cholesterol feeding to rabbits gave rise to a marked decrease in hepatic glutathione S-transferase activity but did not influence glutathione reductase or total glutathione levels. The same treatment had no effect on catalase, glutathione peroxidase and superoxide dismutase. It is concluded that treatment of rabbits with cholesterol-rich diets leading to atherosclerosis gives rise to profound changes in the expression of cytochrome P450 proteins in the liver and other tissues; possible mechanisms are discussed. (C) 1998 Elsevier Science Ireland Ltd. All rights resented.
引用
收藏
页码:179 / 193
页数:15
相关论文
共 59 条
  • [1] ALLAIN CC, 1974, CLIN CHEM, V20, P470
  • [2] [Anonymous], 1985, HDB METHODS OXYGEN R
  • [3] [Anonymous], METHODS ENZYMOLOGY
  • [4] INDUCTION OF CYTOCHROME-P450III AND CYTOCHROME-P450IV FAMILY PROTEINS IN STREPTOZOTOCIN-INDUCED DIABETES
    BARNETT, CR
    GIBSON, GG
    WOLF, CR
    FLATT, PR
    IOANNIDES, C
    [J]. BIOCHEMICAL JOURNAL, 1990, 268 (03) : 765 - 769
  • [5] ROLE OF KETONE-BODIES IN THE DIABETES-INDUCED CHANGES IN HEPATIC MIXED-FUNCTION OXIDASE ACTIVITIES
    BARNETT, CR
    FLATT, PR
    IOANNIDES, C
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 967 (02) : 250 - 254
  • [6] INDUCTION OF HEPATIC MICROSOMAL-P450-I AND MICROSOMAL-P450-IIB PROTEINS BY HYPERKETONEMIA
    BARNETT, CR
    FLATT, PR
    IOANNIDES, C
    [J]. BIOCHEMICAL PHARMACOLOGY, 1990, 40 (02) : 393 - 397
  • [7] Baudhuin P, 1974, Methods Enzymol, V31, P356
  • [8] BURKE MD, 1983, CHEM-BIOL INTERACT, V45, P243
  • [9] BURKE MD, 1974, DRUG METAB DISPOS, V2, P583
  • [10] CARLBERG I, 1975, J BIOL CHEM, V250, P5475